GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Diaceutics DXRX.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

197.50p

-1.50%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2024

Revenue

£32.2m

FY2016FY2024

Net income

−£1.7m

FY2016FY2024

Free cash flow

−£4.0m

FY2016FY2024

Shareholders' equity

£39.9m

FY2016FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue£32.2m£23.7m£19.5m£13.9m£12.7m£13.4m£10.4m£7.4m£4.6m
Operating income−£2.5m−£3.0m£575,000£550,000−£270,000£2.1m£1.4m£901,300£882,300
Net income−£1.7m−£1.7m£724,000£561,000£263,000£397,900£632,300£663,200£747,100
Diluted earnings per share-0.02-0.020.010.010.000.010.010.010.01

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets£48.6m£46.3m£48.3m£45.0m£43.5m£22.4m£7.8m£5.5m£3.4m
Cash and short-term investments£12.7m£16.7m£19.8m£19.7m£25.3m£11.7m£2.1m£3.1m£1.3m
Total liabilities£8.8m£5.6m£5.7m£4.4m£3.3m£2.2m£5.2m£3.6m£2.4m
Debt£1.1m£1.2m£1.3m£1.6m£118,000£107,500£3.7m£2.1m£1.4m
Shareholders' equity£39.9m£40.8m£42.5m£40.6m£40.2m£20.1m£2.6m£1.9m£1.0m
Shares outstanding84m84m86m85m78m64m70m70m70m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations£651,000£1.3m£5.1m£570,000£253,000−£629,700−£954,000£1.5m£674,000
Capital spending−£4.6m−£4.9m−£4.9m−£5.6m−£6.3m−£2.9m−£1.1m−£282,900−£29,000
Free cash flow−£4.0m−£3.5m£226,000−£5.0m−£6.0m−£3.6m−£2.1m£1.3m£645,000

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023Dec 2022Sept 2022
Revenue£14.6m£19.8m£12.3m£13.8m£9.9m£5.0m£12.0m£6.0m
Operating income−£3.2m£1.1m−£3.6m−£852,000−£2.2m−£1.1m£1.6m£793,000
Net income−£2.4m£881,000−£2.6m−£261,000−£1.5m−£742,000£1.5m£746,000
Diluted earnings per share-0.030.01-0.03-0.00-0.02-0.010.020.01
Total assets£44.4m£48.6m£45.4m£46.3m£46.1m£46.1m£48.3m£48.3m
Cash and short-term investments£10.4m£12.7m£16.7m£16.7m£17.9m£17.9m£19.8m£19.8m
Debt£905,000£907,000£984,000£1.1m£1.1m£1.1m£1.2m£1.2m
Shareholders' equity£37.2m£39.9m£38.7m£40.8m£41.1m£41.1m£42.5m£42.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue32.1%19.1%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings-62.2-42.089.8154.4395.1164.5
Price to sales3.33.13.36.28.24.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.